This HTML5 document contains 103 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://dx.doi.org/10.5582/
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q35125067

rdf:type

wikibase:Item

schema:description

2014年论文 2014 թվականի փետրվարին հրատարակված գիտական հոդված artikulong pang-agham научни чланак artículu científicu espublizáu en 2014 2014年の論文 2014年论文 επιστημονικό άρθρο บทความทางวิทยาศาสตร์ tieteellinen artikkeli videnskabelig artikel (udgivet 2014) article scientifique (publié 2014) teaduslik artikkel bilimsel makale wetenschappelijk artikel wissenschaftlicher Artikel 2014年論文 2014 nî lūn-bûn scientific article 2014年論文 научная статья مقالهٔ علمی articol științific artigo científico (publicado na 2014) mokslinis straipsnis наукова стаття, опублікована в лютому 2014 naučni članak ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scienca artikolo مقالة علمية სამეცნიერო სტატია article científic научни чланак 2014년 논문 artigo científico (publicado na 2014) vedecký článok vetenskaplig artikel 2014年论文 2014年論文 artigo científico 2014年论文 artikull shkencor article scientific artículo científico publicado en 2014 bài báo khoa học 2014年论文 vitenskapelig artikkel мақолаи илмӣ artykuł naukowy 2014年論文 מאמר מדעי سائنسی مضمون articolo scientifico научна статия 2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած 2014年论文 2014年論文 мақолаи илмӣ tudományos cikk vitskapeleg artikkel vědecký článek

p:P577

wds:Q35125067-328ACB1D-6033-42A8-AE68-DBB740B4DFBF

wdt:P577

2014-02-01T00:00:00Z

p:P2093

wds:Q35125067-1D728382-DE12-46E6-A952-2CA95391968F wds:Q35125067-9E18BE11-D45A-450A-A1F8-3743A6C5331B wds:Q35125067-CA462CDE-F072-40A5-B220-B32BC7C051F1 wds:Q35125067-9597C132-122C-4888-91F5-A9B01F0CB102 wds:Q35125067-99205DE1-121E-4C43-A49C-5C1CF5D5CA7E

wdt:P2093

Hongyuan Wang Jinhua Chen Wenfang Wang Xiuli Guo Xinyong Liu

rdfs:label

Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis

skos:prefLabel

Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis

schema:name

Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis

p:P1476

wds:Q35125067-59387C27-5CCD-44F9-8E65-E673518C2922

wdt:P1476

Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis

p:P304

wds:Q35125067-E0AC5FA4-1348-448C-9821-C6B6994C81DA

wdt:P304

33-41

p:P31

wds:Q35125067-E20A8A00-E0F2-4C52-A5F1-9487185B2AEB

wdt:P31

wd:Q13442814

p:P921

wds:Q35125067-2CF36882-224C-471F-91AF-897B209F5708

wdt:P921

wd:Q18936

p:P698

wds:Q35125067-58AF4F1E-2A51-4388-AD04-BD534C8590C7

wdtn:P698

n11:24647156

wdt:P698

24647156

p:P1433

wds:Q35125067-E19BDF64-DB17-4D0D-AC8D-63BA8FFDCAA1

wdt:P1433

wd:Q15752935

p:P433

wds:Q35125067-01F37E15-DE72-429B-B011-EDE8B8DDBFE5

p:P478

wds:Q35125067-7980CF3C-41EE-41BA-AD47-9BE713FB9810

wdt:P433

1

wdt:P478

8

p:P356

wds:Q35125067-28AF959D-1839-4277-883E-7A662387326E

wdtn:P356

n12:DDT.8.33

wdt:P356

10.5582/DDT.8.33